Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of gastrointestinal disorders
3.2.1.2 Dietary and lifestyle changes
3.2.1.3 Increased awareness and self-medication
3.2.1.4 Pharmaceutical advancements
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects and health risks
3.2.2.2 Availability of substitutes
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Pricing analysis, 2023
3.6.1 By region
3.6.2 By key player
3.7 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Drug Class, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Proton pump inhibitors
5.3 Acid neutralizers
5.4 Anti-H.pyloric drugs
5.5 H2 antagonists
5.6 Pro-motility agents
5.7 Prostaglandin analogous
5.8 Other drug classes
Chapter 6 Market Estimates and Forecast, By Indication, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Gastroesophageal reflux disease
6.3 Heartburn
6.4 Indigestion
6.5 Gastritis
6.6 Peptic ulcer disease
6.7 Other indications
Chapter 7 Market Estimates and Forecast, By Dosage, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Tablets
7.3 Liquid
7.4 Other dosages
Chapter 8 Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Oral
8.3 Injectable
Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospital pharmacy
9.3 Online pharmacy
9.4 Retail pharmacy
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East and Africa
10.6.1 Saudi Arabia
10.6.2 South Africa
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Aurobindo Pharma Limited
11.2 Bayer AG
11.3 Bristol Myers Squibb Company
11.4 Cipla Limited
11.5 Dr. Reddy’s Laboratories Ltd.
11.6 F. Hoffmann-La Roche Ltd.
11.7 Gsk plc
11.8 Hikma Pharmaceuticals PLC
11.9 Lupin Limited
11.10 Novartis AG
11.11 Pfizer Inc.
11.12 Sun Pharmaceutical Industries Ltd
11.13 Teva Pharmaceutical Industries Ltd
11.14 The Procter & Gamble Company
11.15 Viatris Inc.
